Document is current
Any future updates will be listed below
-
Authors
Voorhees, Timothy J. https://orcid.org/0000-0001-7603-6454
McLaughlin, Eric M.
Torka, Pallawi https://orcid.org/0000-0002-1681-5883
Florindez, Jorge
Kim, Na Hyun
Moyo, Tamara K.
Reves, Heather
Sumransub, Nuttavut https://orcid.org/0000-0001-7456-0623
Deshpande, Saarang https://orcid.org/0000-0002-9824-9052
Rose, Ashley
Duarte, Cassandra
Faisal, Muhammad Salman
Hamid, Showkat
Subbiah, Suki
Ayyappan, Sabarish
Shea, Lauren
Cortese, Matt
Patel, Krish https://orcid.org/0000-0002-2446-098X
Major, Ajay https://orcid.org/0000-0001-7261-1335
Saeed, Hayder
Svoboda, Jakub
Desai, Sanjal https://orcid.org/0000-0002-7892-2625
Geethakumari, Praveen Ramakrishnan
Hamadani, Mehdi https://orcid.org/0000-0001-5372-510X
Grover, Natalie https://orcid.org/0000-0002-1346-3157
Epperla, Narendranath https://orcid.org/0000-0002-8216-3457
-
Funding
Funding for this research was provided by:
Lymphoma Research Foundation
- License Information
-
More Information
Article History
Received: 25 November 2024
Revised: 10 February 2025
Accepted: 12 March 2025
First Online: 26 March 2025
Competing interests
: NE: Research funding: Beigene, Lilly, and Incyte; Speakers Bureau for Beigene and Genentech, Ad boards for ADC Therapeutics, Lilly, and Ipsen; Honorarium from Novartis. TJV: Advisory Board: Genmab/AbbVie, ADC Therapeutics. Consultancy: Novartis, Recordati, Genmab. Research Funding: Kite, Viracta, Incyte/Morphosys, Genmab/AbbVie, Recordati. TKM: Advisory Board: Kite. Research funding: Genmab, Century Therapeutics, Johnson & Johnson. PRG: Consultancy: Kite/Gilead Pharma, Bristol Myers Squibb (BMS). Advisory Board ADC Therapeutics, Bristol Myers Squibb (BMS), Cellectar Biosciences, Ono Pharma, Ipsen Biopharma and Regeneron Pharma. SS: Advisory Board ADC Therapeutics. CD: Advisory Board: EMD Serono Advisory Board, Cogent Biosciences.
: This retrospective study approved through The Ohio State University institutional review board (Study Number: 2022C0159). Given the retrospective nature of this study, individual patient consent was waived and de-identified data was utilized for analysis. The study was conducted in accordance with relevant guidelines and regulations.
